[ad_1]
COMU Faculty of Engineering Department of Bioengineering Academic staff member Prof. Dr. Unlike his counterparts in the world, Mustafa Kemal Sezgintürk developed a double antibody diagnostic kit.
With the support of ÇOMÜ Scientific Research Projects (BAP) within the scope of ‘Advanced Research Projects’, the most important advantage and difference of the study with respect to its counterparts in the world is that two different antibodies produced in humans, specific virus, can be diagnosed in a single test kit. Therefore, a more reliable test kit was produced that responded in a very short time.
Rector of the COMU Prof. Dr. Sedat Murat PHOTO: DHA
Prof. Dr. Stating that the test kit developed by Mustafa Kemal Sezgintürk was manufactured for the first time in the world, ÇOMÜ Rector Prof. Dr. Sedat Murat said the following:
“Today we announce here the results of our project. He is our faculty member Prof. Dr. A test result developed by our professor Mustafa Kemal Sezgintürk on Covid-19. The interesting thing about this project supported by our scientific research projects is; not in Turkey, a world first test. Because in the world there is an antibody test.
You know, the accuracy rate varies by 63 percent in PCRs. In other words, there is a margin of error around 40 percent, but with this test developed by our teacher, a result of 100 percent is obtained in a short time, that is, 5-10 minutes. In the aftermath, it also determines if you had Covid-19 or not.
Covid-19 is a test that reveals it. It gives fast results and is a test with a 100 percent result. Applications in the world are mainly the study of one protein, but our professor is working on two proteins. Therefore, it has a special feature. We, as Çanakkale Onsekiz Mart University, are very proud of this project ”.
PHOTO: DHA
GIVES CORRECT RESULTS CLOSE TO THE FACE IN 8 MINUTES
Stating that the developed test kit gave results in 8 minutes, ÇOMÜ Faculty of Engineering Department of Bioengineering Professor Prof. Dr. Mustafa Kemal Sezgintürk spoke as follows:
Prof. Dr. Mustafa Kemal Sezgintürk PHOTO: DHA
“We have developed a test kit that targets the antibodies formed in the human immune system with the work we have done with the resources of our university since mid-March.
We are about to complete our work. In a few weeks the optimization work that we will do with real blood samples will finish.
We will have natural initiatives related to mass production, and first it will be necessary to obtain the patent rights of the kit we develop. We will also apply to financial institutions in our country. They also had very serious support in this regard. We are planning to start mass production by presenting our project to major funders in our country such as KOSGEB, TÜBİTAK, Development Agencies and the Ministry of Health. ” (DHA)
[ad_2]
